Summary
The age-adjusted prevalence of PSP as measured in central New Jersey is 1.5 cases per million population, about 1% of that of Parkinson’s disease. Its incidence is 3–4 new cases per million population per year, similar to that of such better-known illnesses as myasthenia gravis, the hereditary ataxias as a group and Tourette syndrome. Median actuarially adjusted survival after symptom onset is 5.9–6.9 years. PSP appears to favor no geographical, racial, ethnic or occupational group, though there is anecdotal evidence for hydrocarbon exposure as a candidate etiologic factor. No familial cases of typical PSP have been proven. The one formal case-control study failed to implicate any particular causal agent and the rural predilection of PD appears to be absent in PSP. Better diagnostic methods, more multi-center organization, additional case-control studies and new etiologic hypotheses are needed in the epidemiological investigation of PSP.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
David NJ, Mackey EA, Smith JL (1968) Further observations in progressive supranuclear palsy. Neurology 18: 349–356.
Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS (1988) Risk factors for progressive supranuclear palsy. Neurology 38: 1546–1552.
Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC (1988) Prevalence and natural history of progressive supranuclear palsy. Neurology 38: 1031–1034.
Golbe LI (1991) Young-onset Parkinson’s disease: a clinical review. Neurology 41: 168–173.
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427–442.
Hynd GW, Pirozzolo FJ, Maletta GJ (1982) Progressive supranuclear palsy. Int J Neurosci 16: 87–98.
Jackson JA, Jankovic J, Ford J (1983) Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 13: 273–278.
Kessler II (1972) Epidemiologic study of Parkinson’s disease. Am J Epidemiol 96: 242–254.
Maher ER, Lees AJ (1986) The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 36: 1005–1008.
Mastaglia FL, Grainger K, Kee F, Sadka M, Lefroy R (1973) Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome): clinical and electrophysiological observations in eleven cases. Proc Aust Assoc Neurol 10: 35–44.
Mata M, Dorovini-Zis K, Wilson M, Young AB (1983) New form of familial Parkinson-dementia syndrome: clinical and pathologic findings. Neurology 33: 1439–1443.
McCrank E, Rabheru K (1989) Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can J Psychiatry 34: 934–935.
McCrank E (1990) PSP risk factors. Neurology 40: 1637.
Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK (1986) Parkinson’s disease in a Scottish city. Br Med J 292: 534–536.
Ohara S, Kondo K, Morita H, Maruyama K, Ikeda S, Yanagisawa N (1992) Progressive supranuclear palsy-like syndrome in two siblings of a consanguineous marriage. Neurology 42: 1009–1014.
Pezzoli G, Ricciardi S, Masotta C, Mariani CB, Carenzi A (1990) n-Hexane induces parkinsonism in rodents. Brain Res 531: 355–357.
Rajput AH, Offord KP, Beard CM, Kurland LT (1984) Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 16: 278–282.
Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–359.
Steele JC (1972) Progressive supranuclear palsy. Brain 95: 693–704.
Tanner CM, Langston JW (1990) Do environmental toxins cause Parkinson’s disease? A critical review. Neurology 40[Suppl] 3: 17–30.
Tetrud JW, Langston JW, Irwin I, Snow B (1990) Acute and persistent parkinsonism associated with ingestion of petroleum product mixture. Ann Neurol 28: 296.
Vieregge P, Glaese A, Ulm G, Kompf D (1992) Familial Parkinson’s disease. Mov Disord 7[Suppl] 1: 23.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Wien
About this paper
Cite this paper
Golbe, L.I. (1994). The epidemiology of PSP. In: Tolosa, E., Duvoisin, R., Cruz-Sánchez, F.F. (eds) Progressive Supranuclear Palsy: Diagnosis, Pathology, and Therapy. Journal of Neural Transmission. Supplementa, vol 42. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6641-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6641-3_20
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82541-9
Online ISBN: 978-3-7091-6641-3
eBook Packages: Springer Book Archive